Skip to content
AtessiaAtessia Life Science Advisors
  • Home
  • Expertise
  • Services
    • Medicines
      • Exploitant – Pharmaceutical establishment
        • Find / Open a French “Exploitant” pharmaceutical company
        • Activities related to quality
        • External communications
        • Relation betwenn healthcare professionals & Compliance
        • Pharmacovigilance
      • Regulatory & Pharmaceutical Strategy
      • Research & Development Consulting
      • Marketing authorisation
        • Registration: Drafting & Submitting MA files
        • Post-MA lifecycle management
    • Medical devices
    • Consulting subscription
    • Audits
    • Regulatory monitoring
    • Training
    • Atessia Vigilances
  • Strengths
  • News
    • Company
    • Events
  • Blog
  • Join Atessia
  • Contact
  • English
    • Français
    • English

Blog

Extension d'AMM versus variation de type II
_Blog

Marketing Autorisation Extension versus type II variation. 

Read more »
November 12, 2025
Désignation orpheline
_Blog

The EMA orphan designation

Read more »
October 29, 2025
Remboursement
_Blog

What reimbursement for drugs in France? 

Read more »
October 29, 2025
La Charte de QUalité des Pratiques Professionnelles : Un Nouveau Cadre pour la Promotion des Produits de Santé
_Blog

The Quality Charter for Promotional Practices: A New Framework for the Promotion of Health Products 

Read more »
October 16, 2025
Atessia Quelle substitution des hybrides en france ?
_Blog

What substitution for hybrid Medicines in France? Status of the ANSM Hybrid Groups Register

Read more »
October 16, 2025
_Blog

What are the differences between the Mutual Recognition Procedure and the Decentralized Procedure ? 

Read more »
September 3, 2025
_Blog

Advertising for medicines: the keys to obtaining a visa in France

Read more »
September 3, 2025
Une image contenant personne, intérieur, soins de santé, verres
_Blog

The French Repository for Generic medicinal Products 

Read more »
June 17, 2025
Qu'est-ce qu'un RMP EU ?
_Blog

What is an EU RMP ?

Read more »
May 20, 2025
L'ICH et son influence sur la réglementation mondiale
_Blog

ICH and its influence on global regulation 

Read more »
May 20, 2025
Paediatric Investigation Plan
_Blog

Paediatric Investigation Plans & paediatric requirements in the EU 

Read more »
May 20, 2025
Comprendre EUDAMED
_Blog

Understanding EUDAMED: The European Database on Medical Devices

Read more »
October 14, 2024
Page1 Page2 Page3 Page4

ATESSIA, Life Science Advisors
3, Rue d’Uzès – 75002 PARIS
hello@atessia.fr
+33 1.70.22.66.19

Atessia Life Science Advisors

Follow-us

Legal notices

Terms and Conditions of Sale

ATESSIA SAS with capital of €5,000.00 I RCS PARIS 827 777 319

Copyright © 2021 | Powered by Atessia